Clinical Predictors of Mortality in Adults with Intellectual Disabilities with and without Down Syndrome. (16th March 2012)

• Record Type: Journal Article
• Authors: Thorpe, Lilian; Pahwa, Punam; Bennett, Vernon; Kirk, Andrew; Nanson, Josephine
• Other Names: Silverman Wayne Academic Editor.
• Is Part Of: Current gerontology and geriatrics research. Volume 2012(2012)
• Publication Date: 2012-03-16
• Subjects: Gerontology -- Periodicals; Geriatrics -- Periodicals; Older people -- Physiology -- Periodicals; Older people -- Health and hygiene -- Periodicals; Older people -- Diseases -- Periodicals; 612.6705
• DOI: 10.1155/2012/943890
• Languages: English
• ISSNs: 1687-7063

Abstract

Abstract : Background. Mood, baseline functioning, and cognitive abilities as well as psychotropic medications may contribute to mortality in adults with and without Down Syndrome (DS). Methods. Population-based (nonclinical), community-dwelling adults with intellectual disabilities (IDs) were recruited between 1995 and 2000, assessed individually for 1–4 times, and then followed by yearly phone calls. Results. 360 participants (116 with DS and 244 without DS) were followed for an average of 12.9 years (range 0–16.1 years as of July 2011). 108 people died during the course of the followup, 65 males (31.9% of all male participants) and 43 females (27.6% of all female participants). Cox proportional hazards modeling showed that baseline practical skills, seizures, anticonvulsant use, depressive symptoms, and cognitive decline over the first six years all significantly contributed to mortality, as did a diagnosis of DS, male gender, and higher age at study entry. Analysis stratified by DS showed interesting differences in mortality predictors. Conclusion. Although adults with DS have had considerable improvements in life expectancy over time, they are still disadvantaged compared to adults with ID without DS. Recognition of potentially modifiable factors such as depression may decrease this risk.